Metabolic effects of IGF-I deficiency: Lessons from mouse models

Shoshana Yakar, Hui Sun, Hong Zhao, Patricia Pennisi, Yuka Toyoshima, Jennifer Setser, Bethel Stannard, Louis Scavo, Derek LeRoith

Research output: Contribution to journalArticle

Abstract

Insulin and insulin-like growth factors (IGFs) belong to the most biologically characterized family of peptides involved in metabolism, growth and development. The cellular responses to the IGFs are mediated primarily by the IGF-I receptor. The IGF-I receptor is a member of the family of tyrosine kinase growth factor receptors, and is highly homologous (70%) to the insulin receptor, especially in the tyrosine kinase domain (84%) ADDIN. Upon ligand binding to the extracellular region, the intrinsic tyrosine kinase domain of the receptor is activated. In the past it was believed that insulin activates primarily metabolic processes while IGFs promote cell growth and differentiation. However, in the last two decades many animal models of IGF-I deficiency and excess revealed the importance of IGF-I in carbohydrate and lipid metabolism and now it is clear that these peptide hormones together with growth hormone (GH) work in a coordinate and interdependent manner. In the circulation, IGFs are bound in a binary complex with a family of high affinity IGF-binding proteins (IGFBPs) ADDIN. However, most of the circulating IGF-I associates with a high molecular weight complex ∼150 KDa consisting of IGFBP-3 and the acid labile subunit (ALS) ADDIN. Once the ternary complex dissociates, the binary complexes of IGFBP-IGFs are removed from the circulation and by crossing the endothelium to reach the target tissues and to interact with cell surface receptors. In the present review we will summarize the role of GH and IGF in somatic growth and focus on the metabolic effects of IGF-I deficiency as assessed in various mouse models.

Original languageEnglish (US)
Pages (from-to)11-19
Number of pages9
JournalPediatric Endocrinology Reviews
Volume3
Issue number1
StatePublished - Sep 2005

Fingerprint

Somatomedins
Insulin-Like Growth Factor Binding Proteins
IGF Type 1 Receptor
Insulin-Like Growth Factor I
Protein-Tyrosine Kinases
Growth Hormone
Insulin
Insulin-Like Growth Factor Binding Protein 3
Growth Factor Receptors
Peptide Hormones
Insulin Receptor
Carbohydrate Metabolism
Receptor Protein-Tyrosine Kinases
Cell Surface Receptors
Growth
Growth and Development
Lipid Metabolism
Endothelium
Insulin-Like Growth Factor I Deficiency
Cell Differentiation

Keywords

  • Growth Hormone
  • Insulin resistance
  • Insulin-Like Growth Factor-I

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Yakar, S., Sun, H., Zhao, H., Pennisi, P., Toyoshima, Y., Setser, J., ... LeRoith, D. (2005). Metabolic effects of IGF-I deficiency: Lessons from mouse models. Pediatric Endocrinology Reviews, 3(1), 11-19.

Metabolic effects of IGF-I deficiency : Lessons from mouse models. / Yakar, Shoshana; Sun, Hui; Zhao, Hong; Pennisi, Patricia; Toyoshima, Yuka; Setser, Jennifer; Stannard, Bethel; Scavo, Louis; LeRoith, Derek.

In: Pediatric Endocrinology Reviews, Vol. 3, No. 1, 09.2005, p. 11-19.

Research output: Contribution to journalArticle

Yakar, S, Sun, H, Zhao, H, Pennisi, P, Toyoshima, Y, Setser, J, Stannard, B, Scavo, L & LeRoith, D 2005, 'Metabolic effects of IGF-I deficiency: Lessons from mouse models', Pediatric Endocrinology Reviews, vol. 3, no. 1, pp. 11-19.
Yakar S, Sun H, Zhao H, Pennisi P, Toyoshima Y, Setser J et al. Metabolic effects of IGF-I deficiency: Lessons from mouse models. Pediatric Endocrinology Reviews. 2005 Sep;3(1):11-19.
Yakar, Shoshana ; Sun, Hui ; Zhao, Hong ; Pennisi, Patricia ; Toyoshima, Yuka ; Setser, Jennifer ; Stannard, Bethel ; Scavo, Louis ; LeRoith, Derek. / Metabolic effects of IGF-I deficiency : Lessons from mouse models. In: Pediatric Endocrinology Reviews. 2005 ; Vol. 3, No. 1. pp. 11-19.
@article{7535f17617e94066947ae94739d848a3,
title = "Metabolic effects of IGF-I deficiency: Lessons from mouse models",
abstract = "Insulin and insulin-like growth factors (IGFs) belong to the most biologically characterized family of peptides involved in metabolism, growth and development. The cellular responses to the IGFs are mediated primarily by the IGF-I receptor. The IGF-I receptor is a member of the family of tyrosine kinase growth factor receptors, and is highly homologous (70{\%}) to the insulin receptor, especially in the tyrosine kinase domain (84{\%}) ADDIN. Upon ligand binding to the extracellular region, the intrinsic tyrosine kinase domain of the receptor is activated. In the past it was believed that insulin activates primarily metabolic processes while IGFs promote cell growth and differentiation. However, in the last two decades many animal models of IGF-I deficiency and excess revealed the importance of IGF-I in carbohydrate and lipid metabolism and now it is clear that these peptide hormones together with growth hormone (GH) work in a coordinate and interdependent manner. In the circulation, IGFs are bound in a binary complex with a family of high affinity IGF-binding proteins (IGFBPs) ADDIN. However, most of the circulating IGF-I associates with a high molecular weight complex ∼150 KDa consisting of IGFBP-3 and the acid labile subunit (ALS) ADDIN. Once the ternary complex dissociates, the binary complexes of IGFBP-IGFs are removed from the circulation and by crossing the endothelium to reach the target tissues and to interact with cell surface receptors. In the present review we will summarize the role of GH and IGF in somatic growth and focus on the metabolic effects of IGF-I deficiency as assessed in various mouse models.",
keywords = "Growth Hormone, Insulin resistance, Insulin-Like Growth Factor-I",
author = "Shoshana Yakar and Hui Sun and Hong Zhao and Patricia Pennisi and Yuka Toyoshima and Jennifer Setser and Bethel Stannard and Louis Scavo and Derek LeRoith",
year = "2005",
month = "9",
language = "English (US)",
volume = "3",
pages = "11--19",
journal = "Pediatric Endocrinology Reviews",
issn = "1565-4753",
publisher = "YS Medical Media Ltd.",
number = "1",

}

TY - JOUR

T1 - Metabolic effects of IGF-I deficiency

T2 - Lessons from mouse models

AU - Yakar, Shoshana

AU - Sun, Hui

AU - Zhao, Hong

AU - Pennisi, Patricia

AU - Toyoshima, Yuka

AU - Setser, Jennifer

AU - Stannard, Bethel

AU - Scavo, Louis

AU - LeRoith, Derek

PY - 2005/9

Y1 - 2005/9

N2 - Insulin and insulin-like growth factors (IGFs) belong to the most biologically characterized family of peptides involved in metabolism, growth and development. The cellular responses to the IGFs are mediated primarily by the IGF-I receptor. The IGF-I receptor is a member of the family of tyrosine kinase growth factor receptors, and is highly homologous (70%) to the insulin receptor, especially in the tyrosine kinase domain (84%) ADDIN. Upon ligand binding to the extracellular region, the intrinsic tyrosine kinase domain of the receptor is activated. In the past it was believed that insulin activates primarily metabolic processes while IGFs promote cell growth and differentiation. However, in the last two decades many animal models of IGF-I deficiency and excess revealed the importance of IGF-I in carbohydrate and lipid metabolism and now it is clear that these peptide hormones together with growth hormone (GH) work in a coordinate and interdependent manner. In the circulation, IGFs are bound in a binary complex with a family of high affinity IGF-binding proteins (IGFBPs) ADDIN. However, most of the circulating IGF-I associates with a high molecular weight complex ∼150 KDa consisting of IGFBP-3 and the acid labile subunit (ALS) ADDIN. Once the ternary complex dissociates, the binary complexes of IGFBP-IGFs are removed from the circulation and by crossing the endothelium to reach the target tissues and to interact with cell surface receptors. In the present review we will summarize the role of GH and IGF in somatic growth and focus on the metabolic effects of IGF-I deficiency as assessed in various mouse models.

AB - Insulin and insulin-like growth factors (IGFs) belong to the most biologically characterized family of peptides involved in metabolism, growth and development. The cellular responses to the IGFs are mediated primarily by the IGF-I receptor. The IGF-I receptor is a member of the family of tyrosine kinase growth factor receptors, and is highly homologous (70%) to the insulin receptor, especially in the tyrosine kinase domain (84%) ADDIN. Upon ligand binding to the extracellular region, the intrinsic tyrosine kinase domain of the receptor is activated. In the past it was believed that insulin activates primarily metabolic processes while IGFs promote cell growth and differentiation. However, in the last two decades many animal models of IGF-I deficiency and excess revealed the importance of IGF-I in carbohydrate and lipid metabolism and now it is clear that these peptide hormones together with growth hormone (GH) work in a coordinate and interdependent manner. In the circulation, IGFs are bound in a binary complex with a family of high affinity IGF-binding proteins (IGFBPs) ADDIN. However, most of the circulating IGF-I associates with a high molecular weight complex ∼150 KDa consisting of IGFBP-3 and the acid labile subunit (ALS) ADDIN. Once the ternary complex dissociates, the binary complexes of IGFBP-IGFs are removed from the circulation and by crossing the endothelium to reach the target tissues and to interact with cell surface receptors. In the present review we will summarize the role of GH and IGF in somatic growth and focus on the metabolic effects of IGF-I deficiency as assessed in various mouse models.

KW - Growth Hormone

KW - Insulin resistance

KW - Insulin-Like Growth Factor-I

UR - http://www.scopus.com/inward/record.url?scp=32244435641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32244435641&partnerID=8YFLogxK

M3 - Article

C2 - 16369209

AN - SCOPUS:32244435641

VL - 3

SP - 11

EP - 19

JO - Pediatric Endocrinology Reviews

JF - Pediatric Endocrinology Reviews

SN - 1565-4753

IS - 1

ER -